US EditionIrish Biotech Ovagen delivers breakthrough in vaccine manufacturing efficiency | Manufacturing & Supply Chain
Summary by Industry & Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Irish Biotech Ovagen delivers breakthrough in vaccine manufacturing efficiency | Manufacturing & Supply Chain
Ovagen Group Limited,an innovation-led Irish biotech, has announced groundbreaking results from a Yellow Fever virus yield study that could transform the economics of global vaccine manufacturing. Conducted at The Pirbright Institute (UK), a world-renowned centre tackling viral diseases of livestock, the comparative study showed that Ovagen’s Germ Free embryonated chicken eggs deliveredup to 7,600 doses of yellow fever virus 17D per egg. This yi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
